Related Experiment Video
Updated: Jul 16, 2026
Long-Term Mouse Spinal Cord Organotypic Slice Culture as a Platform for Validating Cell Transplantation in Spinal Cord Injury
Published on: April 12, 2024
Transcriptomics Insights into Spinal Cord Injury for Therapy Development
Daria Chudakova1, Olga Astakhova2, Matthew Shkap1,2,3
1Center for Precision Genetic Technologies for Medicine, Engelhardt Institute of Molecular Biology of the Russian Academy of Sciences, 119991 Moscow, Russia.
Abstract:
Traumatic spinal cord injury (SCI) is a severe medical condition, often resulting in permanent disability, with significant impacts on patients' quality of life and burden on healthcare systems. Current therapeutic approaches for SCI are insufficient, advocating for the development of more effective treatments. As changes in transcriptome post-SCI can provide clues for novel treatment strategies and targets, substantial efforts have been made recently to characterize such transcriptional changes and their spatiotemporal features. This narrative review focuses on how transcriptomics, alone or in combination with other omics data, can contribute to understanding SCI pathobiology and the mechanisms of post-SCI regeneration and guide the development of novel SCI therapies. It covers an arsenal of tools for transcriptomics studies and provides a concise summary of findings from the latest relevant studies (predominantly from 2020 to 2025), representing the major directions in the field.
Insights
Transcriptomics reveals critical gene expression changes after spinal cord injury (SCI). This research highlights how analyzing these transcriptional shifts can guide the development of new therapies for SCI recovery.
Area of Science:
- Neuroscience
- Genomics
- Regenerative Medicine
Background:
- Traumatic spinal cord injury (SCI) leads to severe disability and significant healthcare burdens.
- Current SCI treatments are inadequate, necessitating novel therapeutic strategies.
- Understanding SCI's molecular underpinnings is crucial for advancing treatment options.
Purpose of the Study:
- To review how transcriptomics aids in understanding SCI pathobiology and regeneration mechanisms.
- To explore the role of transcriptomics, often combined with other omics data, in identifying therapeutic targets for SCI.
- To summarize recent findings (2020-2025) in SCI transcriptomics research.
Main Methods:
- This narrative review synthesizes information from recent scientific literature.
- It covers various transcriptomic tools and analytical approaches.
- The review focuses on studies investigating transcriptional changes post-SCI.
Main Results:
- Transcriptomic analyses reveal spatiotemporal gene expression alterations following SCI.
- These analyses provide insights into the molecular pathways involved in SCI.
- Recent studies highlight transcriptomic data's potential for uncovering novel therapeutic targets.
Conclusions:
- Transcriptomics is a powerful tool for deciphering SCI's complex molecular landscape.
- Understanding transcriptional changes is key to developing effective strategies for SCI regeneration and treatment.
- Integrating transcriptomics with other omics data offers a comprehensive approach to SCI research.
Related Concept Videos
01:14Spinal Cord Injury ll: Pathophysiology
01:25Secondary Spinal Cord Injury llI: Pathophysiology